☰
✕

HepG2 Hepatocarcinoma Apoptosis Assay

Link To Website Link To Webstore
Standard Number GTA-6
Organization Nanotechnology Characterization Laboratory
Level National
Category Specification
Status
  • JAN 2010 Published
ABSTRACT
This protocol describes the monitoring of nanoparticle treated human hepatocarcinoma cells (HepG2) for apoptosis, as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes a fluorescent method to determine the degree of caspase-3 activation.